• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成非细胞毒性聚(酯-胺)树枝状大分子作为药物的潜在增溶剂:以甲氨蝶呤为例。

Synthesis of non-cytotoxic poly(ester-amine) dendrimers as potential solubility enhancers for drugs: methotrexate as a case study.

机构信息

Instituto de Investigaciones en Materiales, Universidad Nacional Autónoma de México, Apartado Postal 70-360, CU, Coyoacán, Mexico, DF, 04510, Mexico.

出版信息

Molecules. 2010 Nov 9;15(11):8082-97. doi: 10.3390/molecules15118082.

DOI:10.3390/molecules15118082
PMID:21063271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6259256/
Abstract

This study describes the synthesis of two new families of dendrimers based on the esterification of N-alkylated 3-amine-1-propanol with two different cores, adipic acid (1st and 2nd generations) and ethylenediamine (generation 1.5), both with carboxylic acid end groups, offering a wide variety of further modifications at the periphery. According to the cytotoxic evaluation of the dendrimers and their possible degradation products within cell lines, these materials could be considered as innocuous. In preliminary studies, the synthesized dendrimers proved to be potential enhancers of solubility of highly hydrophobic drugs, like methotrexate, widely used in chemotherapy.

摘要

本研究描述了基于 N-烷基化 3-胺-1-丙醇与两种不同核心(己二酸(第一代和第二代)和乙二胺(第一代半代))的酯化反应合成的两种新型树状大分子,这两种核心都具有羧酸末端基团,为外围提供了多种进一步修饰的可能性。根据树状大分子及其在细胞系中可能的降解产物的细胞毒性评估,这些材料可被视为无害。在初步研究中,合成的树状大分子被证明是提高高度疏水性药物(如广泛用于化疗的甲氨蝶呤)溶解度的潜在增溶剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/60fa9f23625a/molecules-15-08082-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/0b0ccbf6cf37/molecules-15-08082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/9f7af722a82d/molecules-15-08082-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/3708e52cee22/molecules-15-08082-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/0d4c12eb4f2a/molecules-15-08082-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/807035e243d4/molecules-15-08082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/aa1c68727594/molecules-15-08082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/60fa9f23625a/molecules-15-08082-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/0b0ccbf6cf37/molecules-15-08082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/9f7af722a82d/molecules-15-08082-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/3708e52cee22/molecules-15-08082-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/0d4c12eb4f2a/molecules-15-08082-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/807035e243d4/molecules-15-08082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/aa1c68727594/molecules-15-08082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe1a/6259256/60fa9f23625a/molecules-15-08082-g004.jpg

相似文献

1
Synthesis of non-cytotoxic poly(ester-amine) dendrimers as potential solubility enhancers for drugs: methotrexate as a case study.合成非细胞毒性聚(酯-胺)树枝状大分子作为药物的潜在增溶剂:以甲氨蝶呤为例。
Molecules. 2010 Nov 9;15(11):8082-97. doi: 10.3390/molecules15118082.
2
Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies.基于包封研究的聚(酰胺胺)树枝状大分子作为喜树碱药物载体的潜力。
Eur J Med Chem. 2008 Aug;43(8):1791-5. doi: 10.1016/j.ejmech.2007.09.030. Epub 2007 Dec 7.
3
Synthesis of novel dendrimers having aspartate grafts and their ability to enhance the aqueous solubility of model drugs.合成具有天冬氨酸接枝的新型树枝状大分子及其提高模型药物水溶性的能力。
Eur J Med Chem. 2010 Jun;45(6):2705-11. doi: 10.1016/j.ejmech.2010.01.069. Epub 2010 Feb 2.
4
Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery.设计具有内部功能化的全乙酰化树枝状聚合物作为抗癌药物载体。
Biomaterials. 2011 Dec;32(36):9950-9. doi: 10.1016/j.biomaterials.2011.09.016. Epub 2011 Sep 22.
5
Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.树枝状聚合物作为潜在的药物载体。第一部分。在聚酰胺胺树枝状聚合物存在下非甾体抗炎药的增溶作用。
Eur J Med Chem. 2005 Nov;40(11):1188-92. doi: 10.1016/j.ejmech.2005.06.010. Epub 2005 Sep 8.
6
A comparative study on solubility improvement of tetracycline and dexamethasone by poly(propylene imine) and polyamidoamine dendrimers: An insight into cytotoxicity and cell proliferation.聚亚丙基胺和聚酰胺-胺树枝状聚合物对四环素和地塞米松增溶作用的比较研究:细胞毒性和细胞增殖的深入研究。
J Biomed Mater Res A. 2020 Mar;108(3):485-495. doi: 10.1002/jbm.a.36830. Epub 2019 Nov 14.
7
Evaluation of phenylbutazone and poly(amidoamine) dendrimers interactions by a combination of solubility, 2D-NOESY NMR, and isothermal titration calorimetry studies.通过溶解度、二维核Overhauser效应光谱(2D-NOESY NMR)和等温滴定量热法研究相结合的方式评估保泰松与聚(酰胺胺)树枝状大分子的相互作用。
J Pharm Sci. 2009 Mar;98(3):1075-85. doi: 10.1002/jps.21519.
8
Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs.具有聚乙二醇接枝的聚酰胺-胺树枝状大分子的合成及其包封抗癌药物的能力。
Bioconjug Chem. 2000 Nov-Dec;11(6):910-7. doi: 10.1021/bc0000583.
9
Solubility of nicotinic acid in polyamidoamine dendrimer solutions.烟酸在聚酰胺胺树枝状大分子溶液中的溶解度。
Eur J Med Chem. 2005 Dec;40(12):1384-9. doi: 10.1016/j.ejmech.2005.08.001. Epub 2005 Oct 13.
10
Cytotoxicity and biodistribution studies on PEGylated EDA and PEG cored PAMAM dendrimers.聚乙二醇化乙二胺和聚乙二醇为核的聚酰胺-胺树枝状大分子的细胞毒性和生物分布研究。
J Biomater Sci Polym Ed. 2016 Nov;27(16):1645-58. doi: 10.1080/09205063.2016.1226044. Epub 2016 Sep 11.

本文引用的文献

1
Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy.生物医学应用中的树枝状聚合物:从诊断和治疗的潜力到临床应用
Angew Chem Int Ed Engl. 2002 Apr 15;41(8):1329-34. doi: 10.1002/1521-3773(20020415)41:8<1329::aid-anie1329>3.0.co;2-p.
2
In vivo biological evaluation of high molecular weight hyperbranched polyglycerols.高分子量超支化聚甘油的体内生物学评价
Biomaterials. 2007 Nov;28(32):4779-87. doi: 10.1016/j.biomaterials.2007.07.046. Epub 2007 Aug 15.
3
In vitro biological evaluation of high molecular weight hyperbranched polyglycerols.
高分子量超支化聚甘油的体外生物学评价
Biomaterials. 2007 Nov;28(31):4581-90. doi: 10.1016/j.biomaterials.2007.07.011. Epub 2007 Aug 3.
4
Selective cytotoxicity of pancratistatin-related natural Amaryllidaceae alkaloids: evaluation of the activity of two new compounds.水仙环素相关天然石蒜科生物碱的选择性细胞毒性:两种新化合物的活性评估
Cancer Cell Int. 2007 Jun 5;7:10. doi: 10.1186/1475-2867-7-10.
5
Designing dendrimers for biological applications.设计用于生物应用的树枝状大分子。
Nat Biotechnol. 2005 Dec;23(12):1517-26. doi: 10.1038/nbt1171.
6
A surface-modified dendrimer set for potential application as drug delivery vehicles: synthesis, in vitro toxicity, and intracellular localization.一种用于潜在药物递送载体应用的表面修饰树枝状大分子:合成、体外毒性和细胞内定位。
Chemistry. 2004 Mar 5;10(5):1167-92. doi: 10.1002/chem.200305386.
7
Dendrimers in drug research.药物研究中的树枝状大分子。
Chem Soc Rev. 2004 Jan 10;33(1):43-63. doi: 10.1039/b309043b. Epub 2003 Dec 5.
8
Dendritic molecular capsules for hydrophobic compounds.用于疏水性化合物的树枝状分子胶囊。
J Am Chem Soc. 2003 Dec 17;125(50):15485-9. doi: 10.1021/ja0347383.
9
Synthesis and biological activity of polygalloyl-dendrimers as stable tannic acid mimics.
Bioorg Med Chem Lett. 2002 Jun 17;12(12):1567-70. doi: 10.1016/s0960-894x(02)00245-7.
10
Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation.
Bioconjug Chem. 2002 May-Jun;13(3):453-61. doi: 10.1021/bc010103m.